top of page
grey-9026_256.gif

$1.1 Million EBITDA, Electrotherapy TENS Device Company in Texas

Listing Code:

TXDME1W

State:

Texas

Category:

DME & HME

Asking Price:

$9,000,000

Revenue:

$2,900,000

TXDME1W
Company Overview

PRIME exits® and American HealthCare Capital are pleased to exclusively introduce a well-established medical device company specializing in non-invasive electro-therapy solutions designed to alleviate pain and improve patient outcomes. The company has built a strong reputation over more than two decades by providing high-quality Transcutaneous Electrical Nerve Stimulation (TENS) devices and related therapeutic products to healthcare providers and their patients.

Core Competencies
  • Strong physician and therapist referral network driving consistent revenue

  • Robust compliance program

  • Customized, easy-to-use electro-therapy devices that support at-home patient care

  • Decades of industry experience with a loyal customer base

  • Scalable business model with recurring revenue streams

Differentiators
  • High revenue growth of 84% CAGR over 3 years

  • Strong Adjusted EBITDA Margins of 38% and Gross Profit Margin of 77%

  • Patient growth rates of 87% CAGR from 218 to 1,443 over 3 years

  • Robust compliance program

  • Physician and Therapist-driven referrals, ensuring strong medical credibility and patient retention

Product and Payer Mix

The Company’s product mix is 90% Electrodes, 5% TENS Devices, and 5% Braces. The Company’s payer mix consists of 100% Commercial Insurance.

Staff Overview

The Company’s team is expected to remain in place under new ownership, including 8 employees and 7 independent contractors.

Financial Overview

The Company’s revenue has increased significantly from 2022 to 2025 at a compounded annual growth rate (CAGR) of 84% while achieving a 34% adjusted EBITDA margin. The Company expects to continue its double-digit growth rates from a strong first quarter of new patients in 2026.  Total 2026 revenues are forecasted to grow to $2.9 million and $1.1 million in Adjusted EBITDA (38%).

Asking Price

The asking price is $9 Million plus an earn-out going forward. The Seller will consider a majority sale and rollover of equity while remaining involved post-close. This does not include cash, receivables, or working capital

Inquire About This Listing:

In order to learn more about our listing, you must:

1. Complete a Buyer Profile:

This profile will be used to pre-qualify buyers and determine whether we can share additional details about our listings. If you have already completed a Buyer Profile, disregard.

YOU ONLY NEED TO COMPLETE A BUYER PROFILE ONCE. 

2. Sign NDA with Listing Code:

To learn more about this listing, you must sign an NDA. When completing the NDA, you will need to copy the exact LISTING CODE and LISTING TITLE.

Listing Code:

TXDME1W

Listing Title:

$1.1 Million EBITDA, Electrotherapy TENS Device Company in Texas

Heading 4

Need to learn more before Signing an NDA- Contact the Lead Advisor For This Mandate

Listing Title:

Error
Error

Contact the Team

Jack Eskenazi American Healthcare Capital

Jack Eskenazi

President/Founder

American HealthCare Capital

Dr. Allen Nazeri DDS MBA.jpg

Dr. Allen Nazeri 

Managing Partner

PRIME exits

Join our mailing list to receive our latest news, and listings

About PRIME exits®

​PRIME exits® is a middle-market M&A advisory firm focused on founder-led, owner-operated, and legacy businesses across Healthcare, Engineering, Manufacturing, Robotics, Automation, and related sectors. We represent business owners seeking a full or partial liquidity event and provide strategic guidance designed to prepare companies for institutional capital, enhance valuation, and position them for successful transactions with strategic acquirers, private equity firms, family offices, and institutional investors.

Our services include exit planning, value enhancement, transaction preparation, buyer identification, negotiation support, and transaction execution. We work closely with founders and executive teams to help maximize shareholder value and achieve their personal and financial objectives.

Important Disclosure

PRIME exits® does not provide legal, tax, accounting, investment, or other regulated professional advice. Clients are encouraged to seek independent advice from qualified legal, tax, accounting, and financial professionals regarding matters specific to their circumstances.

From time to time, PRIME exits® may introduce clients to third-party service providers, including attorneys, accountants, quality of earnings providers, consultants, lenders, valuation experts, and other professionals. Any fees collected on behalf of such third-party providers are processed solely as an administrative convenience. PRIME exits® does not assume responsibility for the services, advice, or work product of any third-party provider.

PRIME exits® is a registered trademark of Nazeri & Company LLC (United States) and Nazeri & Company Co., Ltd. (Thailand), two separate and independent legal entities operating within their respective jurisdictions.

Healthcare-related transactions are conducted through American Healthcare Capital and its affiliated partners, subject to applicable regulatory and licensing requirements.

Through PRIME exits®, American Healthcare Capital, and their affiliated independent managing directors, advisory services are provided across more than 35 virtual office locations throughout the United States, Southeast Asia, and Europe. Each independent managing director operates under separate contractual arrangements and may be subject to jurisdiction-specific licensing, regulatory, and professional requirements.

Locations
bottom of page